2024-07-15T12:09:26+03:00[Europe/Moscow] en true <p>when the receptor site becomes active. Example: After morphine agonist attaches to a Mu receptor, the receptor activates and produces analgesia, euphoria and respiratory depression.</p>, <p>is the strength of attraction between a drug and its receptor.</p>, <p>is a measure of total systemic exposure to the drug.</p>, <p>is the extent a substance or drug becomes completely available to its intended biological destination. Some factors that influence bioavailability include first-pass metabolism, route of administration, and chemical properties of the drug.</p>, <p>is when two drugs are equal in the rate and extent to which the active pharmaceutical ingredient (API) becomes available at the site(s) of drug action.</p>, <p>(Drug metabolism) is the enzymatic alteration of drug structure. Most drug metabolism takes place in the liver.</p>, <p>is a natural protective membrane that prevents central nervous system (CNS) from toxins and pathogens in blood.&nbsp;</p>, <p>increase the rate of hepatic metabolism decrease serum concentrations of other drugs metabolized by the same hepatic isoenzyme.</p>, <p>decrease the rate of hepatic metabolism and increase serum concentrations of other drugs metabolized by the same hepatic isoenzyme.</p>, <p>is the time it takes for the concentration of the drug in the plasma or the total amount in the body to be reduced by 50%.</p>, <p>the rapid inactivation of certain oral drugs</p>, <p>is the ability to dissolve through the lipid (fat) portion of a membrane.</p>, <p>&nbsp;All drugs cross the placenta to some degree but several factors determine the degree of placental transfer. Major determinants include lipid/water solubility, molecular weight, degree of ionization, and protein binding. Drugs that are lipid soluble, smaller have a low ionized fraction, and non-protein bound tend to cross the placenta to a greater degree.&nbsp;</p>, <p>is the degree to which medications&nbsp;attach to&nbsp;blood proteins&nbsp;within the&nbsp;blood plasma. A&nbsp;drug's&nbsp;efficacy&nbsp;may be affected by the degree to which it binds. The less bound a drug is, the more efficiently it can traverse or diffuse through&nbsp;cell membranes.</p>, <p>is a compound with little or no pharmacological activity that metabolizes inside the body and converts into a pharmacologically active drug compound.&nbsp;</p>, <p>is the substance on which an enzyme acts</p>, <p>is the dosage range or blood plasma or serum concentration usually expected to achieve the desired therapeutic effect.</p> flashcards

Pharmacology Module 1

FNU PC707 Module 1

  • when the receptor site becomes active. Example: After morphine agonist attaches to a Mu receptor, the receptor activates and produces analgesia, euphoria and respiratory depression.

    Activation

  • is the strength of attraction between a drug and its receptor.

    Affinity

  • is a measure of total systemic exposure to the drug.

    Area under the curve

  • is the extent a substance or drug becomes completely available to its intended biological destination. Some factors that influence bioavailability include first-pass metabolism, route of administration, and chemical properties of the drug.

    Bioavailability

  • is when two drugs are equal in the rate and extent to which the active pharmaceutical ingredient (API) becomes available at the site(s) of drug action.

    Bioequivalence

  • (Drug metabolism) is the enzymatic alteration of drug structure. Most drug metabolism takes place in the liver.

    Biotransformation

  • is a natural protective membrane that prevents central nervous system (CNS) from toxins and pathogens in blood. 

    Blood-brain barrier

  • increase the rate of hepatic metabolism decrease serum concentrations of other drugs metabolized by the same hepatic isoenzyme.

    CYP enzyme inducers 

  • decrease the rate of hepatic metabolism and increase serum concentrations of other drugs metabolized by the same hepatic isoenzyme.

    CYP enzyme inhibitors

  • is the time it takes for the concentration of the drug in the plasma or the total amount in the body to be reduced by 50%.

    Drug half-life

  • the rapid inactivation of certain oral drugs

    First-pass hepatic metabolism

  • is the ability to dissolve through the lipid (fat) portion of a membrane.

    Lipid solubility

  •  All drugs cross the placenta to some degree but several factors determine the degree of placental transfer. Major determinants include lipid/water solubility, molecular weight, degree of ionization, and protein binding. Drugs that are lipid soluble, smaller have a low ionized fraction, and non-protein bound tend to cross the placenta to a greater degree. 

    Placental drug transfer

  • is the degree to which medications attach to blood proteins within the blood plasma. A drug's efficacy may be affected by the degree to which it binds. The less bound a drug is, the more efficiently it can traverse or diffuse through cell membranes.

    Protein Binding

  • is a compound with little or no pharmacological activity that metabolizes inside the body and converts into a pharmacologically active drug compound. 

    Prodrug

  • is the substance on which an enzyme acts

    Substrate

  • is the dosage range or blood plasma or serum concentration usually expected to achieve the desired therapeutic effect.

    Therapeutic range